Athi Welsh

Athi’s research interest is in the use of multinuclear metal-based molecules as chemotherapeutic agents. This metal-based approach provides a novel, lesser-explored route to eradicating cancer and potentially provides a new mode of action, a nascent field of research, targeting diseases not only endemic to sub-Saharan Africa but also globally. Athi completed his tertiary studies at the University of Cape Town (UCT), graduating with a B.Sc. in chemistry and molecular cell biology in 2016 and a B.Sc. Honours in chemistry in 2017 and M.Sc. in chemistry in 2019. Currently, his Ph.D. is under examination at the University of Cape Town.